Recruiting NA INTERVENTIONAL 3-arm
NCT07417046
Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopia Using Optical Coherence Tomography Angiography (OCTA) And Visual Evoked Potential (VEP). The Aim Of The Study Is To Evaluate Possible Beneficial Effects For Different Age Groups. (VA; OCTA; VEP;)
Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopia Using Optical Coherence Tomography Angiography (OCTA) And Visual Evoked Potential (VEP)
Sponsor: Minia University
Interventions
Flouxetine Patching therapy
Updated 1 time since 2026 Last updated: Feb 10, 2026 Started: Dec 1, 2024 Primary completion: Mar 1, 2026 Completion: Apr 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07417046, this NA trial focuses on Amblyopia and VEP and remains actively recruiting participants. Sponsored by Minia University, it has been updated 1 time since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Minia University
Data source: Minia University
For direct contact, visit the study record on ClinicalTrials.gov .